231 related articles for article (PubMed ID: 24218101)
1. Developments in CD4 and viral load monitoring in resource-limited settings.
Rowley CF
Clin Infect Dis; 2014 Feb; 58(3):407-12. PubMed ID: 24218101
[TBL] [Abstract][Full Text] [Related]
2. Challenges in implementing HIV laboratory monitoring in resource-constrained settings: how to do more with less.
Bélec L; Bonn JP
Future Microbiol; 2011 Nov; 6(11):1251-60. PubMed ID: 22082287
[TBL] [Abstract][Full Text] [Related]
3. Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.
; Keiser O; Tweya H; Boulle A; Braitstein P; Schecter M; Brinkhof MW; Dabis F; Tuboi S; Sprinz E; Pujades-Rodriguez M; Calmy A; Kumarasamy N; Nash D; Jahn A; MacPhail P; Lüthy R; Wood R; Egger M
AIDS; 2009 Sep; 23(14):1867-74. PubMed ID: 19531928
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of highly active antiretroviral therapy in HIV infection.
Walker AS; Gibb DM
Curr Opin Infect Dis; 2011 Feb; 24(1):27-33. PubMed ID: 21150591
[TBL] [Abstract][Full Text] [Related]
5. The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations.
Hyle EP; Jani IV; Rosettie KL; Wood R; Osher B; Resch S; Pei PP; Maggiore P; Freedberg KA; Peter T; Parker RA; Walensky RP
AIDS; 2017 Sep; 31(15):2135-2145. PubMed ID: 28906279
[TBL] [Abstract][Full Text] [Related]
6. Modelling response to HIV therapy without a genotype: an argument for viral load monitoring in resource-limited settings.
Revell AD; Wang D; Harrigan R; Hamers RL; Wensing AM; Dewolf F; Nelson M; Geretti AM; Larder BA
J Antimicrob Chemother; 2010 Apr; 65(4):605-7. PubMed ID: 20154024
[TBL] [Abstract][Full Text] [Related]
7. CD4 count-based failure criteria combined with viral load monitoring may trigger worse switch decisions than viral load monitoring alone.
Hoffmann CJ; Maritz J; van Zyl GU
Trop Med Int Health; 2016 Feb; 21(2):219-23. PubMed ID: 26584666
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.
Boyer S; March L; Kouanfack C; Laborde-Balen G; Marino P; Aghokeng AF; Mpoudi-Ngole E; Koulla-Shiro S; Delaporte E; Carrieri MP; Spire B; Laurent C; Moatti JP;
Lancet Infect Dis; 2013 Jul; 13(7):577-86. PubMed ID: 23602084
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of ART in resource-limited countries.
Loubiere S; Meiners C; Sloan C; Freedberg KA; Yazdanpanah Y
Curr Opin HIV AIDS; 2010 May; 5(3):225-31. PubMed ID: 20539078
[TBL] [Abstract][Full Text] [Related]
10. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
Chang LW; Harris J; Humphreys E
Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
[TBL] [Abstract][Full Text] [Related]
11. Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value.
Oliveira R; Krauss M; Essama-Bibi S; Hofer C; Robert Harris D; Tiraboschi A; de Souza R; Marques H; Succi R; Abreu T; Della Negra M; Hazra R; Mofenson LM; Siberry GK;
Clin Infect Dis; 2010 Dec; 51(11):1325-33. PubMed ID: 21039218
[TBL] [Abstract][Full Text] [Related]
12. A model for reduced HIV-1 viral load monitoring in resource-limited settings.
Bryant L; Smith N; Keiser P
J Int Assoc Provid AIDS Care; 2013; 12(1):67-71. PubMed ID: 22553318
[TBL] [Abstract][Full Text] [Related]
13. Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings.
Kantor R; Diero L; Delong A; Kamle L; Muyonga S; Mambo F; Walumbe E; Emonyi W; Chan P; Carter EJ; Hogan J; Buziba N
Clin Infect Dis; 2009 Aug; 49(3):454-62. PubMed ID: 19569972
[TBL] [Abstract][Full Text] [Related]
14. Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges.
Roberts T; Cohn J; Bonner K; Hargreaves S
Clin Infect Dis; 2016 Apr; 62(8):1043-8. PubMed ID: 26743094
[TBL] [Abstract][Full Text] [Related]
15. Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives?
Braithwaite RS; Nucifora KA; Yiannoutsos CT; Musick B; Kimaiyo S; Diero L; Bacon MC; Wools-Kaloustian K
J Int AIDS Soc; 2011 Jul; 14():38. PubMed ID: 21801434
[TBL] [Abstract][Full Text] [Related]
16. Beyond first-line HIV treatment regimens: the current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings.
Kumarasamy N; Krishnan S
Curr Opin HIV AIDS; 2013 Nov; 8(6):586-90. PubMed ID: 24100872
[TBL] [Abstract][Full Text] [Related]
17. Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting.
van Zyl GU; Preiser W; Potschka S; Lundershausen AT; Haubrich R; Smith D
Clin Infect Dis; 2011 Jan; 52(2):264-70. PubMed ID: 21288854
[TBL] [Abstract][Full Text] [Related]
18. A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries.
Colebunders R; Moses KR; Laurence J; Shihab HM; Semitala F; Lutwama F; Bakeera-Kitaka S; Lynen L; Spacek L; Reynolds SJ; Quinn TC; Viner B; Mayanja-Kizza H
Lancet Infect Dis; 2006 Jan; 6(1):53-9. PubMed ID: 16377535
[TBL] [Abstract][Full Text] [Related]
19. Monitoring treatment: at what cost?
Cohen J
Science; 2004 Jun; 304(5679):1936. PubMed ID: 15218140
[No Abstract] [Full Text] [Related]
20. Dried blood spots in HIV monitoring: applications in resource-limited settings.
Johannessen A
Bioanalysis; 2010 Nov; 2(11):1893-908. PubMed ID: 21083497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
